The study deals with interactions of polyelectrolytes polystyrene sulfonate and hyaluronic acid with nitrogenic amphiphilic substances, represented by lysine and albumine. To study the interactions pH-metry, conductance, viscositic and turbidity measurement, DLS and reometry were used. All mixtures of different concentrations were measured and the data were compered with data obtained from measurement of samples with amphiphilic sumstances without polyelectrolytes. Observed interactions occured in the aminoacid concentrations between 0 to 20 mmoldm-3, then the PSS interaction groups were fully bonded by lysine and no more interactions were recognized. The same behaviour were observed in albumine solutions with concentration under 2 gdm-3.

This diploma thesis deals with an experimental analysis of lubricant film formation in hip joint replacements. The main objective is to clarify the effect of mean speed, slide-to-roll ratio, and material of femoral head on the development of film thickness, focusing on the role of particular constituents contained in model synovial fluid, such as albumin and -globulin. For this purpose, a model ball-on-disc configuration was applied, while the development of lubricant film was evaluated using the combination of fluorescent microscopy and optical interferometry. To better understand the process, coefficient of friction between implant surfaces was later investigated as well. The effect of material, slide-to-roll ratio, mean speed and model fluid composition was analysed. Results indicate that the main parameter, influencing the character of film formation, is slide-to-roll ratio. Under most conditions, the dominant constituent responsible for the film thickness development was albumin. Coefficient of friction is affected mainly by the material of implant. The thesis contains original scientific results extending the knowledge in the area of hip joint biotribology.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20080号 / 医博第4173号 / 新制||医||1018(附属図書館) / 33196 / 京都大学大学院医学研究科医学専攻 / (主査)教授 長船 健二, 教授 川口 義弥, 教授 小川 修 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

Targeted radionuclide therapy is becoming a widely used cancer treatment strategy. By radiolabeling receptor-specific peptides, cancer cells overexpressing the receptor can be selectively targeted, and the cytotoxic radionuclide can be delivered to the target cell or tissue for therapeutic or diagnostic purposes. Bombesin analogues have been previously developed and utilized to target the gastrin-releasing peptide receptor (GRPR), a receptor commonly overexpressed in prostate cancer cells. The RM26 analogue derived from the native bombesin is an antagonistic ligand of GRPR and a possible candidate for targeted radiotherapy. Prolonging the half-life of the molecule is an important aspect of developing a new protein therapeutic. Using albumin binding domain (ABD) for this purpose is an emerging strategy in recent years. ABD is able to bind to serum albumin and thus remains in the blood circulation for a long period of time. It is also a scaffold for protein engineering efforts and by coupling receptor-specific ligands to ABD, the target-specific binding along with extended in vivo halflife can be achieved. In this project, an RM26 analogue with a PEG linker and ABD with a DOTA chelator for future radiolabeling were synthesized with solid phase peptide synthesis (SPPS), conjugated, purified by RP-HPLC and analyzed by mass spectrometry. The binding properties of the conjugate were evaluated by SPR-based biosensory studies, and further experiments are planned for the testing the product and its potential application in radionuclide therapy. / Riktad radioterapi är en allt vanligare metod för behandling av cancer. Genom att radioinmärka receptor-specifika peptider kan dessa selektivt levereras till tumörceller som uttrycker receptorn. Radioterapi kan användas för diagnostik eller terapi, beroende på kopplad radionuklid. Bombesinanaloger har utvecklats och använts för att selektivt binda gastrinfrisättande peptidreceptor (gastrin-releasing peptide receptor, GRPR), en receptor som ofta är överuttryckt i prostatacancer. Bombesinanalogen RM26, som har sitt ursprung från nativt bombesin, är en antagonist till GRPR och kan möjligen användas för riktad radioterapi av prostatacancer. Vid utvecklingen av nya proteinläkemedel är halveringstiden i serum en viktig aspekt. En nyligen utvecklad strategi för att förlänga halveringstiden i serum är fusion av det  tumörspecifika proteinet till en albumin-bindande domän (ABD). ABD binder till albumin, ochsåledes kan fusionsproteinet bevaras i blodcirkulationen under en längre tid. I detta projekt, har både RM26 med en PEG-linker, och ABD med en DOTA kelator syntetiserats med fastfaspeptidsyntes (solid phase peptide synthesis, SPPS). RM26-PEG och DOTA-ABD har därefter konjugerats, renats med RP-HPLC och analyserats med massspektrometri. Bindning till albumin har utvärderats med ytplasmonresonans (surface plasmon resonance, SPR). Vidare studier planeras för att utvärdera peptid-proteinkonjugatet och dess potential för riktad radioterapi.

I characterize the behavior of microcantilever arrays which utilize the in-plane photonic transduction that I've previously developed and evaluate the performance of the microcantilever arrays in simple sensing scenarios with integrated microfluidics. First the thermal responses of microcantilevers with a variety of patterns of deposited gold films are compared. Using a scanning electron microscope, I observe the deflection thermal sensitivities of 300 µm long microcantilevers to be -170.82 nm/K for a full gold coating and -1.93 nm/K for no gold coating. Using the photonic transduction method I measure a thermal sensitivity of -1.46 nm/K for a microcantilever array with no gold. A microcantilever array integrated with microfluidics is exposed to a solution of bovine serum albumin (BSA) followed by solutions of various pH's. In all cases I observe a previously unreported transient deflection response. We find that the transient response is due to temporary nonuniform concentration distributions. In response to nonspecific binding of BSA, I observe a transient surface stress of -0.23 mN/m that agrees well with the -0.225 mN/m predicted by simulations. We hypothesize that the deflection response to pH changes is due to stress generated by conformational changes of bound BSA.The deflection response of an integrated microcantilever array to different types of flow and different flow rates is observed. Simulations of the deflection response match well with experimental results but disagree at higher flow rates. For flow rates greater than 200 µL/min, the limitation of the differential signal's dynamic range becomes apparent. We then investigate flow driven by an on-chip reciprocating reservoir pump. We demonstrate that it is possible to use the reciprocating pump to achieve high flow rates while making deflection measurements in-between reservoir actuations. Investigations of the microcantilever array noise show that flicker noise dominates below 10 Hz, while above 10 Hz, readout noise dominates. A minimum deflection noise density of 15 pW/√Hz is achieved. To improve the signal-to-noise ratio I develop algorithms for a digital lock-in amplifier with a digital phase-lock loop. In simulation the lock-in amplifier is able to improve the SNR by up to a factor of 6000, and self-lock to a noisy carrier signal without an external reference signal.

In-situ chain extension of polymers used in the formulation of artificial tears and mild gelation are techniques to increase the residence time of eye drops on cornea. In-situ chain extension also helps to control the stability of ophthalmic emulsions both in the bottle and in the tear film. In this work, the interaction of hydrophobically modified guar and tear proteins as a method of polymer chain extension and mild gelation has been evaluated. Guar and its derivatives have been found to be very effective for ophthalmic applications. The ideal guar gelation agent is the one that turns on the gelation upon introduction onto the eye and that gelation chemistry is biocompatible and biodegradable. Controllable gelation is desirable to have relatively low viscosity eye drops for easy application and the drops form weak gels in the eye. One recent strategy to cure dry eye disease is to include emulsions in lubricant eye drops. The idea is to supplement the natural lipid layer on the exterior surface of the tear film. Formulating artificial tear emulsions is relatively complicated and must satisfy conflicting criteria. Emulsion droplets should be stable over the period of their shelf life without creaming or aggregate formation. On the other hand, in the tear film the emulsion droplets must cream fast enough and deposit onto the water/lipid film interface on the exterior surface of the tear film. Thus, the emulsion must be stable but not too stable. Initially, science-based design rules were proposed for the development of future generations of lubricant eye drops. The effect of guar molecular weight and concentration on emulsion stability was evaluated. According to the concentration-molecular weight plot, polymer solutions can be divided into stable and unstable regions. They are defined based on the critical flocculation concentration (CFC) and critical viscosity concentration (C*). Inverted QCM-D has been proposed as a simple and fast method to define the stability of oil in water emulsion systems. This technique is a promising alternative for time consuming conventional creaming experiments. Low molecular weight guar can be optimized to out-perform high molecular weight guars without the complications of formulating eye drops with high molecular weight polymers. Hydroxypropyl guar samples were oxidized and modified with linear alkyl amines to give a series of hydrophobically modified guars (MGuars). Lysozyme and human serum albumin (HSA), natural tear proteins, are able to extend the effective chain length of MGuar through polymer/protein complex formation. Hydrophobic modifications on guar enable efficient interaction with proteins, through their mutual hydrophobic characteristics. The interaction of proteins with various alkyl chain lengths, degrees of substitution and a range of molecular weights were examined. Binding and rheological measurements were employed to evaluate the interactions efficiency. Our results suggest that higher degrees of substitution and longer alkyl chain length give higher viscosity values. Lowering molecular weight allows for higher concentration, while keeping the initial viscosity constant. Higher viscosity was achieved as the chain extension occurred. The influence of hydrophobic modification and molecular weight variation on lubrication behavior of MGuars has also been determined. Hydrophobic modification enhanced the lubrication between hydrophobic surfaces. However, saturation of hydrophobes with protein abolished the lubricity. / Thesis / Doctor of Philosophy (PhD)

No description available.

No description available.

Cancer is still one of the most common causes of death world-wide and in parallel there is a need to update the repertoire of therapies that withstand resistance of recurrent cancers. Since the introduction of antibody therapies as anti-cancer pharmaceuticals, recognized as immunotherapy in health care, it has been an increasing field in cancer therapy, as a more targeted treatment compared to chemotherapy. Despite the great success, immunotherapy rely on parenteral administration, partly due to poor tissue penetration. If the treatment is administered intravenously, specialized personnel is required, in addition to that it can be inconvenient for the patient. Also, pharmaceuticals based on antibodies often require costly production steps which yields a high-priced treatment. To approach this problem, researchers have developed small affinity domains with the aim to increase tissue penetration while keeping a high specificity to its target. Albumin Binding Domain Derived Affinity Protein (ADAPT) is an example of a small affinity domain of only 7 kDa, which is based on albumin binding domain (ABD) from the streptococcal protein G. Recently, it was shown that the ADAPTs can be further engineered to bind albumin and another relevant target protein of interest simultaneously, which suggests a tolerable half-life in patient serum, alternative administration routes and lower production costs compared to antibody treatments. Furthermore, less side effects are expected due to higher specificity compared to chemotherapy. This work presents the characterization of novel ADAPT proteins that the target the cancer relatedproteins C-C motif ligand 7 (CCL7), vascular endothelial growth factor A (VEGF-A) and carcinoembryonic antigen related cell adhesion molecule 5 (CEACAM5). The new constructs were produced recombinantly in Escherichia coli (E. coli) and purified using affinity chromatography. Moreover, the results demonstrate bispecific binding with high affinity towards serum albumin and CCL7 and CEACAM5 respectively, while the ADAPT variants targeting VEGF-A remain to be further developed. Lastly, the importance of different amino acids for structural and binding properties of one CEACAM5 binder are stated. It reveals that the target binding relies on hydrophobic interactions which also can be connected to its poor structural attributes. Accordingly, this project adds new insights about the ADAPTs which can be useful in research towards future clinical applications aimed to improve cancer treatments.